Pomerantz Roger
SEC insider (Form 3/4/5 filer). CIK 0001614936. Director at Enlivex Ltd. (ENLV) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2025. Located in CARDIFF, CA.
Companies Pomerantz Roger has filed insider reports for
- Enlivex Ltd. (ENLV): Director
- Indaptus Therapeutics, Inc. (INDP): Director
- Viracta Therapeutics, Inc. (VIRX): Director
Pomerantz Roger
CIK: 0001614936
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 10, 2025INDP
Indaptus Therapeutics, Inc.
AwardDirectStock Option (right to buy)
30K shares- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
500 shares at avg. $0.50- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
250 shares at avg. $0.50- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
250 shares at avg. $0.50- - Nov 25, 2024VIRX
Viracta Therapeutics, Inc.
ExerciseDirect9K shares- - Aug 25, 2024VIRX
Viracta Therapeutics, Inc.
ExerciseDirect9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2025 |  INDP Indaptus Therapeutics, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition Stock Option (right to buy) | 500 | $0.50 | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition Stock Option (right to buy) | 250 | $0.50 | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition Stock Option (right to buy) | 250 | $0.50 | - | Direct |
| Nov 25, 2024 |  VIRX Viracta Therapeutics, Inc. | Exercise | 9,034 | - | $0 | Direct |
| Aug 25, 2024 | VIRX Viracta Therapeutics, Inc. | Exercise | 9,034 | - | $0 | Direct |
1-6 of 6 transactions